Filing Details
- Accession Number:
- 0001209191-21-003345
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-12 21:43:01
- Reporting Period:
- 2021-01-11
- Accepted Time:
- 2021-01-12 21:43:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | Biological Products, (No Disgnostic Substances) (2836) | 464233385 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1813796 | Paul Sauer | C/O Vaxcyte, Inc. 353 Hatch Drive Foster City CA 94404 | Svp Process Dev, Manufacturing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-11 | 2,500 | $1.79 | 80,399 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-11 | 973 | $25.38 | 79,426 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-11 | 1,527 | $26.74 | 77,899 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-01-11 | 2,500 | $0.00 | 2,500 | $1.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 26,426 | 2027-05-17 | No | 4 | M | Direct |
Footnotes
- Includes 1,284 shares acquired under the Employee Stock Purchase Plan on November 17, 2020.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $25.08 to $25.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $26.35 to $27.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- 1/4 of the shares subject to the option vested on March 4, 2018, and 1/48 of the shares vest monthly thereafter.
Billionaire Hedge Funds
